These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 299880)

  • 21. The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions.
    Stanton TH; Calkins CE; Jandinski J; Schendel DJ; Stutman O; Cantor H; Boyse EA
    J Exp Med; 1978 Oct; 148(4):963-73. PubMed ID: 702065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concanavalin A-induced activation of lymphocytic choriomeningitis virus memory lymphocytes into specifically cytotoxic T cells.
    Marker O; Thomsen AR; Andersen GT
    Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):483-6. PubMed ID: 305190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte-mediated cytotoxicity against tumor cells. III Differentiation of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):317-20. PubMed ID: 136357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte-mediated cytotoxicity against tumor cells II. Characteristics and tissue distribution of concanavalin A-activated cytotoxic effector cells.
    Waterfield JD; Waterfield EM
    Eur J Immunol; 1976 May; 6(5):309-16. PubMed ID: 1086781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro studies of cellular-mediated immunostimulation of tumor growth.
    Fidler IJ
    J Natl Cancer Inst; 1973 May; 50(5):1307-12. PubMed ID: 4712593
    [No Abstract]   [Full Text] [Related]  

  • 26. On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.
    Forman J
    J Exp Med; 1975 Aug; 142(2):403-18. PubMed ID: 1079848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P; Burakoff S; Dorf ME; Benacerraf B
    J Exp Med; 1977 May; 145(5):1387-92. PubMed ID: 67179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.
    Bevan MJ; Cohn M
    J Immunol; 1975 Feb; 114(2 Pt 1):559-65. PubMed ID: 123541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of antigen-specific cytotoxicity by concanavalin A at the peak of response to tumor allografts.
    Shimamoto Y; Nomoto K; Taniguchi K; Kubo C
    Cell Immunol; 1979 Sep; 47(1):204-10. PubMed ID: 92366
    [No Abstract]   [Full Text] [Related]  

  • 32. T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.
    Wagner H; Röllinghoff M
    J Exp Med; 1978 Dec; 148(6):1523-38. PubMed ID: 309919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the mechanism of lymphocyte- mediated cytolysis. VIII. The use of con A to delineate a distinctive killer T cell subpopulation.
    Rubens RP; Henney CS
    J Immunol; 1977 Jan; 118(1):180-6. PubMed ID: 299755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat anti-lymphocyte alloantibodies block con A-stimulation of T lymphocytes: inhibition of a polyclonally specific T cell reaction.
    Wekerle H
    Adv Exp Med Biol; 1976; 66():403-8. PubMed ID: 1083646
    [No Abstract]   [Full Text] [Related]  

  • 36. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
    Shellam GR; Knight RA; Mitchison NA; Gorczynski RM; Maoz A
    Transplant Rev; 1976; 29():249-76. PubMed ID: 58459
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cytotoxic T lymphocyte activity by concanavalin A.
    Sitkovsky MV; Pasternack MS; Eisen HN
    J Immunol; 1982 Oct; 129(4):1372-6. PubMed ID: 6980931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct evidence for a two-signal mechanism of cytotoxic T-lymphocyte activation.
    Teh HS; Teh SJ
    Nature; 1980 May; 285(5761):163-5. PubMed ID: 6966377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN; Dorf ME; Benacerraf B
    J Exp Med; 1975 Oct; 142(4):1023-8. PubMed ID: 809532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concanavalin A induces suppressor cell activity in both T gamma and T non-gamma cells: most of the suppressor cells do not carry HLA-DR antigens.
    Dobloug JH; Førre O; Chattopadhyay C; Natvig JB
    Scand J Immunol; 1982 Jan; 15(1):87-95. PubMed ID: 6461918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.